Guest guest Posted January 12, 2008 Report Share Posted January 12, 2008 In a message dated 1/11/2008 10:11:47 PM Pacific Standard Time, PoWeRTX@... writes: Umm, what does anyone think? Is this a way for pharma to increase sales or is there strong evidence? I trust the UK docs a lot since they have said things in the past that US docs would not admit. Given that the UK has a single-payer universal healthcare system, they wouldn't approve such an expensive move if they didn't think it was cost-effect--ie reduce cardiovascular disease in diabetics--saving them money in the long run. Since they have good record keeping, it will be interesting to see whether the side effects (rhabdomyolosis, liver toxicity, etc) are worth the therapy. Jeff in Palm SpringsStart the year off right. Easy ways to stay in shape in the new year. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 12, 2008 Report Share Posted January 12, 2008 In a message dated 1/11/2008 10:11:47 PM Pacific Standard Time, PoWeRTX@... writes: Umm, what does anyone think? Is this a way for pharma to increase sales or is there strong evidence? I trust the UK docs a lot since they have said things in the past that US docs would not admit. Given that the UK has a single-payer universal healthcare system, they wouldn't approve such an expensive move if they didn't think it was cost-effect--ie reduce cardiovascular disease in diabetics--saving them money in the long run. Since they have good record keeping, it will be interesting to see whether the side effects (rhabdomyolosis, liver toxicity, etc) are worth the therapy. Jeff in Palm SpringsStart the year off right. Easy ways to stay in shape in the new year. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.